Top compounds associated with response to SPRY2


Feature Type Standardized
Nominal ANOVA
mRNA PD-0325901 CCLE pan-cancer AAC 0.43 9e-21
mRNA AZD6244 CCLE pan-cancer AAC 0.42 2e-18
mRNA PLX4720 CCLE pan-cancer AAC 0.21 2e-05
mRNA RAF265 CCLE pan-cancer AAC 0.23 4e-05
mRNA Nilotinib CCLE pan-cancer AAC 0.13 0.03
mRNA Panobinostat CCLE pan-cancer AAC -0.092 0.05
mRNA AZD0530 CCLE pan-cancer AAC 0.1 0.05
mRNA TKI258 CCLE pan-cancer AAC 0.086 0.1
mRNA Irinotecan CCLE pan-cancer AAC -0.091 0.1
mRNA lapatinib CCLE pan-cancer AAC -0.068 0.2
Download CSV